This report from the European Commission funded "European Health Risk Assessment Network on Electromagnetic Fields Exposure (EFHRAN)" group considers and reviews the latest published research exploring possible effects on humans from EMF in order to identify any potential health concerns.

Both epidemiological and experimental studies are considered, for cancer and non-cancer endpoints with separate analyses made for low, intermediate and high frequencies

For High Frequencies the EFHRAN report concludes:

Inclusion of the recent data has not necessitated any revisions to the existing consensus opinions of EMF-NET (2009) or SCENIHR (2009a). For none of the diseases is there sufficient evidence for a causal association between exposure and the risk of the disease, and the strength of evidence for many outcomes remains as inadequate (Table 5).

Results of the international analyses of glioma and meningioma risk in the Interphone study have been published. While an association between mobile phone use and risk of these diseases has not been demonstrated, the study does not either demonstrate an absence of risk. There is at this time inadequate evidence for all endpoints considered. Given that the majority of subjects in Interphone were light users compared to users today, particularly young people, and as the study did not include subjects who used phones for more than 12 years, further research is needed to evaluate the possible association between RF exposure and risk of tumours.

While increased responsiveness to RF fields has not been demonstrated in provocation studies, even in subjects that self-report hypersensitivity, the possibility remains that longterm mobile phone use may induce symptoms, such as migraine and vertigo, and further work is required to clarify this issue

Click here for the EFHRAN Report